Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antagonistic peptide of anti-opioid peptide and application thereof

An anti-opioid peptide and antagonistic peptide technology, applied to the anti-opioid peptide antagonistic peptide and the application field of the antagonistic peptide, can solve the problems of limited effective rate of acupuncture analgesia, tolerance problem of acupuncture and the like

Inactive Publication Date: 2012-07-04
PEKING UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Professor Han Jisheng used an acupuncture treatment device to treat withdrawal symptoms, trying to stimulate the synthesis of endogenous opioids in the body through specific frequency electrical pulse stimulation to relieve symptoms, but its biggest defect is that the effectiveness of acupuncture analgesia in the population is limited and continues Acupuncture also has tolerance issues

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antagonistic peptide of anti-opioid peptide and application thereof
  • Antagonistic peptide of anti-opioid peptide and application thereof
  • Antagonistic peptide of anti-opioid peptide and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] Example 1. Obtainment of anti-opioid peptide 99A and its functional verification

[0086] 1. Obtainment of porcine brain anti-opioid peptide 99A and detection of its dose-dependent effect

[0087] 1. Discovery of anti-opioid peptides

[0088] In the isolated mouse vas deferens specimens, stimulation with a square wave pulse (0.1MS width, 1 time / second) can cause contraction (see the literature for the specific method: J. Hughes et al (1975) Effect of morphine on adrenergic transmission in the Mouse Vas deferens.Assessment of agonist and antagonistpotencies of Narcotic analgesics 53,371-381), then, successively add morphine hydrochloride (3.2nM) or dog brain extract (AOS, 200μg / mL) (for dog brain extract The concentrated solution was successively filtered through Sephadex G-50 gel (purchased from Pharmacia Company), and after cation exchange chromatography on carboxymethyl-cellulose (CM-C was purchased from H.Reeve-Angel&.Co.Ltd Company), the sample was obtained) , to ...

Embodiment 2

[0117]Example 2. Obtaining and Activity Detection of Anti-opioid Peptide 99A Antagonist Peptide

[0118] 1. Obtaining antagonistic peptides of 99A-16, 99A-19 and DBI-16

[0119] According to the principle of interaction between protein molecules, the reference (J.R.Heal et al Specific interactions between sense and complementary peptides: The Basis for the proteomic code ChemBIOChem 2002, 3, 114-131) designed 99A-16, 99A-19 and DBI -16 antagonistic peptides of three short peptides, wherein the antagonistic peptide of 99A-16 is named CP-99A-16+5, has the amino acid residue sequence of SEQ ID NO: 5, consists of 21 amino acid residues, and The coding sequence has the nucleotide sequence of SEQ ID NO: 8 in the sequence table, consisting of 63 bases; the antagonistic peptide of 99A-19 is named CP-99A-19, and has the amino acid residue sequence of SEQ ID NO: 6 , consisting of 19 amino acid residues, its coding sequence has the nucleotide sequence of SEQ ID NO: 9 in the sequence tab...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses anti-opioid peptide, and antagonistic peptide and application thereof. The anti-opioid peptide has one of the following amino acid residue sequences: 1) SEQ ID NO:1 in a sequence table; and 2) the amino acid residue sequence shown as the SEQ ID NO:1 in the sequence table is replaced and deleted by 1 to 10 amino acid residues or added with polypeptide with the effect of resisting morphine damages. The antagonistic peptide has one of the following amino acid residue sequences: 1) SEQ ID NO:5-7 in a sequence table; and 2) the amino acid residue sequence shown as the SEQ ID NO:5-7 in the sequence table is replaced and deleted by 1 to 10 amino acid residues or added with polypeptide with the effects of enhancing morphine analgesia, reversing morphine tolerance and / or weakening or eliminating abstinence syndromes. The anti-opioid peptide and an active segment and the antagonistic peptide thereof exert an important effect in the field of preparation of medicinal and drug treatment medicaments and have wide application prospects.

Description

[0001] This application is a divisional application with the application number 200710100384.4, the filing date is June 11, 2007, and the title of the invention is "anti-opioid peptide and its antagonistic peptide and the application of the antagonistic peptide". technical field [0002] The present invention relates to peptides and their coding genes and applications, in particular to an anti-opioid peptide and its antagonistic peptide which can antagonize the antinociceptive effect of morphine, and the antagonistic peptide can enhance morphine analgesia, reverse morphine tolerance and / or Use in drugs that reduce or eliminate the effects of withdrawal symptoms. Background technique [0003] As we all know, rampant drug trafficking and drug use around the world has become a cancer that endangers society, seriously interfering with orderly economic construction and social stability. In addition, intravenous drug use has also caused a rise in the infection rate of AIDS populati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/08C12N15/11C12N15/63C12N5/10A61K38/10A61P25/36A61P25/04
Inventor 陈玉珍吴才宏曲红
Owner PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com